Hyep Ivan
CIK 2034668
Transactions on file
24
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-08-12 | 2026-08-10 | BCAX Bicara Therapeutics Inc. | Officer Chief Financial Officer | Sale | 12,500 | $349.6K | -17.2% | open → |
| 2026-08-12 | 2026-08-10 | BCAX Bicara Therapeutics Inc. | Officer Chief Financial Officer | Exer. | 12,500 | $47.4K | +511.4% | open → |
| 2026-07-10 | 2026-07-08 | BCAX Bicara Therapeutics Inc. | Officer Chief Financial Officer | Sale | 830 | $25.2K | -23.6% | open → |
| 2026-07-10 | 2026-07-08 | BCAX Bicara Therapeutics Inc. | Officer Chief Financial Officer | Sale | 4,413 | $131.6K | -22.3% | open → |
| 2026-07-10 | 2026-07-08 | BCAX Bicara Therapeutics Inc. | Officer Chief Financial Officer | Sale | 22,757 | $650.9K | -19.0% | open → |
| 2026-07-10 | 2026-07-08 | BCAX Bicara Therapeutics Inc. | Officer Chief Financial Officer | Exer. | 12,500 | $47.4K | +511.4% | open → |
| 2026-05-26 | 2026-05-21 | BCAX Bicara Therapeutics Inc. | Officer Chief Financial Officer | Sale | 9,200 | $187.9K | +13.5% | open → |
| 2026-05-26 | 2026-05-21 | BCAX Bicara Therapeutics Inc. | Officer Chief Financial Officer | Exer. | 9,200 | $34.9K | +511.4% | open → |
| 2026-04-22 | 2026-04-21 | BCAX Bicara Therapeutics Inc. | Officer Chief Financial Officer | Sale | 9,200 | $211.6K | +0.7% | open → |
| 2026-04-22 | 2026-04-21 | BCAX Bicara Therapeutics Inc. | Officer Chief Financial Officer | Exer. | 9,200 | $34.9K | +511.4% | open → |
| 2025-12-23 | 2025-12-22 | BCAX Bicara Therapeutics Inc. | Officer Chief Financial Officer | Sale | 9,200 | $168.5K | +26.5% | open → |
| 2025-12-23 | 2025-12-22 | BCAX Bicara Therapeutics Inc. | Officer Chief Financial Officer | Exer. | 9,200 | $34.9K | +511.4% | open → |
| 2025-11-25 | 2025-11-24 | BCAX Bicara Therapeutics Inc. | Officer Chief Financial Officer | Sale | 17,795 | $330.1K | +24.9% | open → |
| 2025-11-25 | 2025-11-24 | BCAX Bicara Therapeutics Inc. | Officer Chief Financial Officer | Exer. | 17,795 | $67.4K | +511.4% | open → |
| 2025-11-25 | 2025-11-21 | BCAX Bicara Therapeutics Inc. | Officer Chief Financial Officer | Sale | 605 | $11.0K | +27.7% | open → |
| 2025-11-25 | 2025-11-21 | BCAX Bicara Therapeutics Inc. | Officer Chief Financial Officer | Exer. | 605 | $2.3K | +511.4% | open → |
| 2025-10-10 | 2025-10-09 | BCAX Bicara Therapeutics Inc. | Officer Chief Financial Officer | Sale | 6,415 | $116.9K | +27.1% | open → |
| 2025-10-10 | 2025-10-09 | BCAX Bicara Therapeutics Inc. | Officer Chief Financial Officer | Exer. | 6,415 | $24.3K | +511.4% | open → |
| 2025-10-08 | 2025-10-08 | BCAX Bicara Therapeutics Inc. | Officer Chief Financial Officer | Sale | 5,627 | $102.5K | +27.3% | open → |
| 2025-10-08 | 2025-10-08 | BCAX Bicara Therapeutics Inc. | Officer Chief Financial Officer | Exer. | 5,627 | $21.3K | +511.4% | open → |
| 2025-10-08 | 2025-10-07 | BCAX Bicara Therapeutics Inc. | Officer Chief Financial Officer | Sale | 18,244 | $332.4K | +27.2% | open → |
| 2025-10-08 | 2025-10-07 | BCAX Bicara Therapeutics Inc. | Officer Chief Financial Officer | Exer. | 18,244 | $69.1K | +511.4% | open → |
| 2025-10-08 | 2025-10-06 | BCAX Bicara Therapeutics Inc. | Officer Chief Financial Officer | Sale | 6,514 | $118.4K | +27.5% | open → |
| 2025-10-08 | 2025-10-06 | BCAX Bicara Therapeutics Inc. | Officer Chief Financial Officer | Exer. | 6,514 | $24.7K | +511.4% | open → |
